newscontact us

CESCA THERAPEUTICS STRENGTHENS LEADERSHIP TEAM AND BOARD OF DIRECTORS

RANCHO CORDOVA, CA, February 28, 2017 – Cesca Therapeutics Inc. (NASDAQ: KOOL), a market leader in automated cell processing and point-of-care autologous cell-based therapies, today announced that it has appointed Ms. Vivian Liu as its Chief Operating Officer and elected Dr. Russell Medford to its board of directors…(more)